Latest News

Features

denervation

Multi-organ denervation to combat cardiometabolic disease: A novel concept put to...

Following a successful proof-of-concept study, Gerard S Goh and Markus P Schlaich have embarked upon a first-in-human study to explore the safety and efficacy...
new vascular access technologies

Nitric oxide, simulation and “living” grafts: Is the landscape of vascular...

The field of vascular access care for haemodialysis patients may look very different in just a few years’ time, with a host of new,...

Videos

 Andrew Holden (Auckland, New Zealand) presents the latest results from the IN.PACT™ AV Access trial (Medtronic), which indicate “outstanding” target-lesion primary patency rates of 52.2% through 24 months in dialysis patients with dysfunctional arteriovenous fistulas (AVFs), offering a “highly-significant advantage” over standard...